<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have previously described a monoclonal antibody, referred to as 38.13, reacting with most Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) derived lines, either containing the Epstein-Barr virus (EBV) or not, but not reacting with EBV-positive lymphoblastoid cell lines (LCL) </plain></SENT>
<SENT sid="1" pm="."><plain>(PNAS 78: 6485, 1981; Int </plain></SENT>
<SENT sid="2" pm="."><plain>J </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 29: 653, 1982) </plain></SENT>
<SENT sid="4" pm="."><plain>The antibody reacted with 41 BL lines out of 57 tested so far </plain></SENT>
<SENT sid="5" pm="."><plain>The target antigen </plain></SENT>
<SENT sid="6" pm="."><plain>BLA, was shown to be a neutral <z:chebi fb="0" ids="33563">glycolipid</z:chebi>, identified as globotriaosylceramide (<z:chebi fb="125" ids="28260">Gal</z:chebi> alpha 1----4 Gal beta 1----4 Glc beta 1----1 Ceramide) </plain></SENT>
<SENT sid="7" pm="."><plain>This substance is known as Pk blood group antigen, a <z:mpath ids='MPATH_458'>normal</z:mpath> intermediate in the P substance synthesis </plain></SENT>
<SENT sid="8" pm="."><plain>Pk antigen is detectable only on the erythrocytes of very rare individuals with the Pk phenotype </plain></SENT>
<SENT sid="9" pm="."><plain>We showed that 38.13 antibody stained erythrocytes and fibroblasts from 2 Pk subjects, whereas it was unreactive with erythrocytes and fibroblasts of <z:hpo ids='HP_0000001'>all</z:hpo> the other individuals tested </plain></SENT>
<SENT sid="10" pm="."><plain>The accumulation of globotriaosylceramide on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells could reflect some functional disturbance of the enzymes in the P substance synthesis pathway </plain></SENT>
</text></document>